Although it is generally recognized that cephamycins are very stable to many ,-lactamases, Gootz (1) and Minami et al. (2) recently showed that the antibacterial activity of cefoxitin and cefmetazole, which are representative cephamycins, was reduced by a large amount of cephalosporinase or in the cultures of cephalosporinaseproducing bacteria. However, there has been no report dealing with the stability of cephamycins to cephalosporinases in vivo, except that by Xerii (7) . In this study, to clarify the in vivo stability of cephamycins to cephalosporinases, we measured the concentrations of cephamycins (cefoxitin [4] , cefmetazole [6] , and cefbuperazone [5] ) and cefazolin, a cephalosporinasesusceptible cephalosporin, in peritoneal fluid of mice with experimental peritoneal infection caused by each of two bacteria producing different types of cephalosporinase.
Cefbuperazone was synthesized in the Research Laboratory of Toyama Chemical Co. Ltd. Cefoxitin (Daiichi Seiyaku Co. Ltd.), cefmetazole (Sankyo Co. Ltd.), cefazolin (Fujisawa Pharmaceutical Co. Ltd.), and cephaloridine (Torii Yakuhin Co. Ltd.) were commercially available. As the pathogen, Enterobacter cloacae H-27 and Proteus vulgaris T-178 which inducibly produced Ia and Ic cephalosporinases, respectively, were used (2) . week-old mice (strain ICR; weight, 18 to 22 g; Shizuoka Laboratory Animal Center, Shizuoka, Japan) were inoculated intraperitoneally with 1 ml of each suspension (5.0 x 108 cells per ml) of the pathogen in 5% gastric mucin (Nakarai Chemical Co. Ltd., Kyoto, Japan). Noninfected control groups were given intraperitoneally 1 ml of 5% mucin. One hour after the animals were infected, they were administered subcutaneously 100 mg of each antibiotic per kg. A total of 5 to 10 mice from each group were sacrificed by dislocation of the neck at 0.5, 1, 2, 3, and 4 h after the administration of the antibiotic. Peritoneal fluid (200 ,lI) was removed with a micropipette; the peritoneal fluid was immediately diluted with the same volume of methanol and cooled in an ice water bath. These mixtures were then centrifuged at 1,000 x g for 10 min at 4°C and stocked in an ice water bath until they were assayed. The antibiotic concentrations in the peritoneal fluid were determined by bioassay (2) . The thinlayer paper disk method was used, and Klebsiella pneumoniae ATCC 10031 was used as the test organism for * Corresponding author.
cefbuperazone, Micrococcus luteus ATCC 9341 was used for cefoxitin and cefmetazole, and Bacillus subtilis was used ATCC 6633 for cefazolin. Standards of the antibiotics were prepared in 0.67 phosphate buffer (pH 7.0) containing 50% methanol. The immersed paper disks were dried at 37°C for 20 min to eliminate methanol before they were placed on the seeded plates. Data are described as the means ± standard deviation and were evaluated by the Student t test. A high-pressure liquid chromatographic assay was performed to detect the hydrolyzed compound of cephamycins in peritoneal fluid, as described previously (2) . For the determination of the cephalosporinase activity of cells in the peritoneal cavity, the cells were washed out from the peritoneal cavity at 1 and 2 h after drug administration. After large fragments and blood cells were removed by centrifugation (30 x g for 5 min at 4°C) and treatment with distilled water, the crude enzyme was prepared by sonic disruption. P-Lactamase activity was determined by microiodometry (3), using cephaloridine (100 ,uM) as the substrate. In vitro hydrolysis rates of antibiotics by cephalosporinases were also determined by microiodometry.
The in vitro stability of antibiotics to E. cloacae and P. vulgaris cephalosporinases are shown in Table 1 . Very low rates of hydrolysis of cephamycins were observed for these cephalosporinases; in particular, the rate of cefbuperazone hydrolysis was not detectable using the enzyme with high activity. Cefazolin was highly susceptible to both enzymes. Table 2 shows antibiotic concentrations in the peritoneal fluid obtained from the infected mice. Cefoxitin and cefmetazole were not detected in peritoneal fluid from E. cloacae-infected mice after 2 h, whereas both drugs were detected in the peritoneal fluid from P. vulgaris-infected mice as well as the control mice. In the case of cefbuperazone, the concentrations in the infected mice were rather high compared with those in the noninfected controls.
Cefazolin was not detected in the peritoneal fluid from the infected mice at every point tested. The levels of cephamycins in serum in infected mice were not reduced (data not shown). The cephalosporinase activity of the organism in the peritoneal fluid from E. cloacae-infected mice was found to be enhanced by the administration of all B the drugs tested ( Table 3 ). The cephalosporinase activity induced by cefbuperazone was lowest among the drugs tested.
The difference in activity between cefbuperazone and cefoxitin or cefmetazole in peritoneal fluid from E. cloacaeinfected mice can be explained by the following two possibilities. One is that cefbuperazone is more stable to E. cloacae cephalosporinase than are cefoxitin and cefmetazole in vivo as well as in vitro. Another is that the amount of cephalosporinase induced by cefbuperazone in vivo is smaller than those induced by cefoxitin and cefmetazole (Table 3) showed that the reduction of cefmetazole was due to hydrolysis by E. cloacae cephalosporinase. Representative chromatograms for cefmetazole are shown in Fig. 1 . The hydrolyzed compound of cefmetazole was detected in peritoneal fluid from E. cloacae-infected mice but not in peritoneal fluid from control and P. vulgaris-infected mice. The hydrolyzed compound of cefbuperazone was not detected in peritoneal fluid from infected mice. The findings that some of the cephamycins were hydrolyzed by Ta cephalosporinase in vitro and in vivo is of clinical importance.
